Precision medicine in ALK-positive NSCLC: Results from the BFAST trial
Precision medicine in ALK-positive NSCLC: Results from the BFAST trial
Comment: Targeted therapy ivosidenib in cholangiocarcinoma
PLEIADES: Daratumumab combinations for multiple myeloma
Impact of cancer prevention campaigns in Brazil: A google trends analysis
Continuous treatment versus fixed duration therapy: Using real-world evidence to guide treatment paradigms for multiple myeloma
Lung cancer screening and the management of the pulmonary nodule
Cancer control in Africa - Special Issue
An overview of the latest advances in gastric cancer
Using ctDNA to predict recurrence and response in colorectal cancer
Novel methods of drug testing and biopsy in India
Cancer care in Latin America
ASCO 2019 and vision for cancer control